Dasatinib-Teva 50 mg, Filmtabletten - 60 Swissmedic Key 67100004 Registration Holder Teva Pharma AG Name Dasatinib-Teva 50 mg, Filmtabletten Date of registration 03.05.2019 Introduction of Sequence 03.05.2019 ATC-Classification Dasatinib (L01EA02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 60 Index Therapeuticus (Swissmedic) 07.16.10. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680671000047 Medication Code Synthetika Pharmacode Disponibility
Composition dasatinibum 50 mg ut dasatinibum monohydricum, lactosum monohydricum 65.653 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 0.72 mg, magnesii stearas, Überzug: hypromellosum, triacetinum, E 171, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Dasatinib 50 mg
BAG: Active Agent Dose Dasatinib 50 mg
Inactive agents Dose additional_information Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactose Monohydrate 65.653 mg Magnesii Stearas Pro Compresso Obducto Triacetinum
Source Data was imported : 08.08.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
